Princeton, NJ, Nov 15, 2011 (PRWEB) November 16, 2011
TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a leader in the Life Sciences solutions development, has strengthened its Drug Safety & Pharmacovigilance solutions and services offering to cater to the growing needs of Pharma Emerging nations. The Company has partnered with MENE Research wherein they together will cater to the Drug Safety requirements of Middle East, Europe and West Asian countries.
“We are extremely pleased to partner with MENE Research and are sure that our expertise and global presence will help us to further explore the emerging Pharma markets. We will ensure that clients benefit from highly efficient, proactive and affordable solutions and services to meet global pharmacovigilance needs of sponsor companies, affiliates and agencies. Our engagement with MENE is evidence of TAKE Solutions’ comprehensive understanding of the business, the challenges and proven track record of providing intelligent and innovative drug safety operations and pharmacovigilance solutions,” said, Prashanth Visweswaran, Director - Drug Safety Practice, TAKE Solutions.
Sule Mene, CEO, MENE Research says “when we started talks with TAKE Solutions our main criteria was an entity that offered Pharmacovigilance solutions & services which was in compliance with applicable current regulatory and privacy directives and they fulfilled the same to the T. TAKE has a deep understanding of how to translate customer’s drug safety requirements into specific process steps which ensure compliance and proactive analysis thereby improving patient safety. All these factors made us believe that they will be the most beneficial partners in our endeavor to provide Pharma companies Pharmacovigilance services globally.
Both the companies together will work towards providing the life science industry with strategy, solutions and services for drug safety operations thus ensuring global regulatory compliance and effective patient safety methodologies is followed. This partnership becomes strong by the fact that TAKE already has to its credit creating a framework - SafetyReady™ along with a thought leadership in Drug Safety and Pharmacovigilance segments and Mene Research’s regional expertise in Middle East, Europe, West Asia etc.
About MENE Research:
MENE Research is a Turkish Clinical Research Organization (CRO) established in 2002 and located in GOSB TechnoPark nearby Istanbul, Turkey and has become the first trials group to be approved by the country’s Ministry of Health under new trial laws introduced in January, 2009.
MENE Research provides the excellent service due to TURKEY's UNIQUE opportunities (High patient potential, High qualified site staff and low cost), and also operates in most of the countries in Middle East, Europe, West Asia(Armenia, Azarbaijan, Cyprus, Georgia, Greece, Egypt, Iran, Israel, Jordan, Kuwait, Lebanon, Qatar, Saudi Arabia, United Arab Emirates, Uzbekistan). For more information, please visit http://www.meneresearch.com.
About TAKE Solutions
TAKE Solutions, Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suite includes distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes.
TAKE has been recognized as a leader by IDC’s MarketScape Worldwide Life Sciences R&D IT Outsourcing for 2011. TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit http://www.takesolutions.com.